Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 3 933 JPY -4.54% Market Closed
Market Cap: 6.3T JPY

Intrinsic Value

The intrinsic value of one Takeda Pharmaceutical Co Ltd stock under the Base Case scenario is 5 021.7 JPY. Compared to the current market price of 3 933 JPY, Takeda Pharmaceutical Co Ltd is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5 021.7 JPY
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Takeda Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Takeda Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Takeda Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Takeda Pharmaceutical Co Ltd
TSE:4502
JP
Pharmaceuticals
Market Cap
6.2T JPY
IPO
May 16, 1949
JP
Pharmaceuticals
Market Cap
6.2T JPY
IPO
May 16, 1949
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Takeda Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Takeda Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Takeda Pharmaceutical Co Ltd

Current Assets 2.8T
Cash & Short-Term Investments 526.7B
Receivables 735.1B
Other Current Assets 1.5T
Non-Current Assets 12.4T
Long-Term Investments 410.2B
PP&E 2T
Intangibles 9.5T
Other Non-Current Assets 450.4B
Efficiency

Free Cash Flow Analysis
Takeda Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Takeda Pharmaceutical Co Ltd

Revenue
4.6T JPY
Cost of Revenue
-1.6T JPY
Gross Profit
3T JPY
Operating Expenses
-2.5T JPY
Operating Income
479.5B JPY
Other Expenses
-271.4B JPY
Net Income
208.1B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Takeda Pharmaceutical Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
52/100
Profitability
Score

Takeda Pharmaceutical Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Takeda Pharmaceutical Co Ltd's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
38/100
Solvency
Score

Takeda Pharmaceutical Co Ltd's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Takeda Pharmaceutical Co Ltd

Wall Street analysts forecast Takeda Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 4 996.66 JPY with a low forecast of 4 242 JPY and a high forecast of 6 090 JPY.

Lowest
Price Target
4 242 JPY
8% Upside
Average
Price Target
4 996.66 JPY
27% Upside
Highest
Price Target
6 090 JPY
55% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Takeda Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos
What is the Intrinsic Value of one Takeda Pharmaceutical Co Ltd stock?

The intrinsic value of one Takeda Pharmaceutical Co Ltd stock under the Base Case scenario is 5 021.7 JPY.

Is Takeda Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 3 933 JPY, Takeda Pharmaceutical Co Ltd is Undervalued by 22%.

Back to Top